Madryn Asset Management, a holder of approximately 4.2% of the outstanding common stock of SomaLogic (SLGC), issued a presentation detailing why shareholders should reject the company’s proposed merger with Standard BioTools (LAB).
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SLGC: